Integrating Public Health Concerns into Patent Legislation in Developing Countries
(2000; 140 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentTHE SOUTH CENTRE
View the documentFOREWORD
View the documentACKNOWLEDGEMENTS
View the documentGLOSSARY*
Open this folder and view contentsI. INTRODUCTION
Open this folder and view contentsII. PATENTABLE SUBJECT MATTER
Close this folderIII. SCOPE OF CLAIMS
View the documentIII.1 Options - Scope of Claims
Open this folder and view contentsIV. PATENTABILITY REQUIREMENTS
Open this folder and view contentsV. SPECIAL CASES IN PHARMACEUTICALS
Open this folder and view contentsVI. DISCLOSURE
Open this folder and view contentsVII. EXCEPTIONS TO EXCLUSIVE RIGHTS
Open this folder and view contentsVIII. EXAMINATION AND OBSERVATION PROCEDURES
Open this folder and view contentsIX. CLAIMS INTERPRETATION
Open this folder and view contentsX. COMPULSORY LICENSING
View the documentXI. FINAL REMARKS
View the documentREFERENCES
View the documentBACK COVER
 

III.1 Options - Scope of Claims

Several elements may be included in national laws to deal with the issue of the scope of claims. If a country wishes to ensure that the scope of protection is defined as precisely as possible, on the basis of structurally defined claims, it may follow Option 1.

Option 1 would not allow for claims defined solely on the basis of the function that an invention performs, nor the definition of a product through the process for obtaining it.

If, however, a country wished to establish a broader scope of patenting, option 2 would be preferable, since it would permit the granting of patents even if claims are defined in non-structural terms and also “product-by-process claims” but, in this latter case, only in relation to the product that is “obtained” (not “obtainable”) with the process.

Scope of Claims
Model Options

1. The claims of a patent shall define the invention for which protection is sought in terms of its purpose, constitution and effects. A claim which only recites the operation and effects of an invention shall not be accepted. A product claim shall not be admitted if the product is not sufficiently defined as such.

2. Product-by-process claims shall be accepted only when a structural description of the invention is not possible. The protection shall be limited in these cases to the product obtained with the claimed process.

It also may be possible to combine the first part of Option 1 with Option 2, or consider other alternatives.

Policy makers should recognize that, while health-related inventions may require special attention, the rules adopted will apply to all fields of technology, and that the personnel of the Patent Office should be well trained in order to adequately apply the provisions on this matter.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014